Nebenwirkungen · Revlimid
Revlimid 2.5 mg hard capsules Revlimid 5 mg hard capsules Revlimid 7.5 mg hard capsules Revlimid 10 mg hard capsules Revlimid 15 mg hard capsules Revlimid 20 mg hard capsules Revlimid 25 mg hard capsules · Abschnitt 4.8 · PDF-Seite 32
HOS-117128 · Präparat HOS-094537
Table 3. ADRs reported in clinical trials in patients with myelodysplastic syndromes treated with lenalidomide# System Organ All ADRs/Frequency Grade 3−4 ADRs/Frequency Class/Preferred Term Infections and Very Common Very Common Infestations Bacterial, viral and fungal infections Pneumonia◊ (including opportunistic infections)◊ Common Bacterial, viral and fungal infections (including opportunistic infections)◊, Bronchitis Blood and Lymphatic Very Common Very Common System Disorders Thrombocytopenia^, ◊, Neutropenia^, ◊, Thrombocytopenia^, ◊, Neutropenia^, ◊, Anaemia◊, Leucopenia Anaemia◊, Leucopenia
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-09-09T12:08:00Z · SHA-256 0f6cca94a1a136a03ce79918070d9d16a6919ff303eae396136f3a6bdce58c5c · Passage 73b5238317fe8e60cd12651ee2fb6665d4f5dfdde4fcbbecb13e6148a1c38ac2 · Zeichen 29777–31150 im Abschnitt